Medicare Enrolled

Dr. Frank Rubalcava, MD

Cardiovascular Disease · New Braunfels, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1626 E COMMON ST, New Braunfels, TX 78130
8306201272
In practice since 2005 (20 years)
NPI: 1851387070 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rubalcava from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubalcava? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rubalcava

Dr. Frank Rubalcava is a cardiovascular disease in New Braunfels, TX, with 20 years in practice. Based on federal Medicare data, Dr. Rubalcava performed 8,491 Medicare services across 6,122 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rubalcava received a total of $7,796 from 32 pharmaceutical and/or device companies across 375 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rubalcava is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 5% volume in TX$ $7,796 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,491
Medicare services
Top 5% in TX for cardiovascular disease
6,122
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~425 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)1,446$83$388
Electrocardiogram (EKG), 12-lead1,011$10$72
Lipid panel (cholesterol and triglycerides)664$13$60
Blood glucose (sugar) level515$4$23
Echocardiogram, transthoracic403$135$1,003
Regadenoson injection (Lexiscan) for heart stress test372$46$152
Blood draw (venipuncture)371$8$18
Blood test, basic group of blood chemicals (calcium, ionized)345$13$39
Ultrasound of both sides of head and neck blood flow342$134$661
Office visit, established patient (20-29 min)282$66$233
Natriuretic peptide (heart and blood vessel protein) level274$38$156
Chronic care management, first 20 min/month260$47$136
Red blood cell concentration measurement251$2$11
Blood count, hemoglobin251$2$11
Hospital follow-up visit, moderate complexity224$61$217
Prothrombin time test (blood clotting)186$4$26
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician164$49$372
Nuclear medicine studies of heart muscle at rest and with stress and spect123$335$1,741
Anticoagulant management of patient taking warfarin121$6$55
Technetium tc-99m sestamibi, diagnostic, per study dose121$57$517
Programming of dual lead pacemaker system114$29$126
Initial hospital admission, high complexity107$135$570
Remote pacemaker monitoring, 90 days94$19$129
Chronic care management, additional 20 min/month68$36$120
Ultrasound of leg arteries or artery grafts47$173$867
New patient office visit (30-44 min)38$73$335
Initial hospital admission, moderate complexity38$101$394
Hospital follow-up visit, low complexity29$39$109
Blood glucose (sugar) measurement using reagent strip26$5$15
Ultrasound study of arm or leg veins with compression and maneuvers26$130$705
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days24$26$232
Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days20$177$806
Programming of single lead pacemaker system20$24$103
Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days17$18$70
Heart rhythm recording continous external ekg over more than 48 hours up to 7 days15$9$44
Programming of dual lead implantable defibrillator system15$41$171
Programming of multiple lead implantable defibrillator system15$44$209
Troponin (protein) analysis, quantitative14$12$44
Evaluation of single, dual, multiple lead or leadless pacemaker system14$16$68
Myoglobin (muscle protein) level13$13$73
Complete ultrasound of abdomen and pelvis artery and vein blood flow11$207$907
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.2% high complexity
12.8% medium
79.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,796
Total received (2018-2024)
Avg $1,114/year across 7 years
Top 38% in TX for cardiovascular disease
32
Companies
375
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,796 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$563
2023
$728
2022
$990
2021
$1,528
2020
$669
2019
$1,483
2018
$1,834

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$1,527
BOSTON SCIENTIFIC CORPORATION
$1,006
Abbott Laboratories
$543
Novartis Pharmaceuticals Corporation
$540
Boston Scientific Corporation
$493
PFIZER INC.
$410
Amarin Pharma Inc.
$404
Amgen Inc.
$307
Merck Sharp & Dohme LLC
$276
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$265
SANOFI-AVENTIS U.S. LLC
$259
Biosense Webster, Inc.
$209
Esperion Therapeutics, Inc.
$181
AstraZeneca Pharmaceuticals LP
$166
iRhythm Technologies, Inc.
$162
Edwards Lifesciences Corporation
$156
Boehringer Ingelheim Pharmaceuticals, Inc.
$119
Kowa Pharmaceuticals America, Inc.
$95
Inari Medical, Inc.
$93
Akcea Therapeutics, Inc.
$88
Medtronic Vascular, Inc.
$79
Relypsa, Inc.
$73
AngioDynamics, Inc.
$72
Merck Sharp & Dohme Corporation
$66
Allergan Inc.
$52
Regeneron Healthcare Solutions, Inc.
$37
E.R. Squibb & Sons, L.L.C.
$32
CVRx, Inc.
$32
Braemar Manufacturing, LLC
$19
ARALEZ PHARMACEUTICALS US INC.
$13
Otsuka America Pharmaceutical, Inc.
$12
Aziyo Biologics, Inc.
$9
Top 3 companies account for 39.5% of total payments
Associated products mentioned in payments ›
ALLURE QUADRA · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Assurity Pacemaker · BRILINTA · BYSTOLIC · Barostim Neo System · CARDIOMEMS · CHANTIX · Cardiac Monitoring Suite · CardioMEMS HF System · Carto 3 System · Confirm Rx · Corlanor · ECM · ELIQUIS · ENTRESTO · EVKEEZA · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FLOWTRIEVER CATHETER · GALLANT · GENERAL TACHY · GENERAL THERAPIES · GENERAL TACHY · GENERAL THERAPIES · GENERAL - BRADY · GENERAL - THERAPIES · GENERAL METALLIC STENTS · GENERAL TACHY · GENERAL THERAPIES · GENERAL VASCULAR ACCESS · HeartMate · HeartMate 3 Left Ventricular Assist Device · JARDIANCE · LATITUDE · LEQVIO · LUX DX · LifeVest · Livalo · MULTAQ · NEXLETOL · PRADAXA · PRALUENT · Quadra Assura CRT Defibrillator · Repatha · Reveal LINQ · S · SAMSCA · SAPIEN 3 Ultra RESILIA · TEGSEDI · UNIFY ASSURA · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · XARELTO · Xience Sierra Coronary Stent · ZIO XT Patch · ZONTIVITY · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $92 per 100 Medicare services performed
Looking for a cardiovascular disease in New Braunfels?
Compare cardiovascular diseases in the New Braunfels area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
34
Per 100K population
19.1
County median income
$93,776
Nearest hospital
RESOLUTE HEALTH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rubalcava is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rubalcava experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rubalcava performed 1,446 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rubalcava receive payments from pharmaceutical companies?
Yes. Dr. Rubalcava received a total of $7,796 from 32 companies across 375 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubalcava's costs compare to other cardiovascular diseases in New Braunfels?
Dr. Rubalcava's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubalcava) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →